The Xpeng G9 SUV is on display during the 20th Shanghai International Automobile Industry Exhibition at the National Exhibition and Convention Center in Shanghai, April 18, 2023.
VCG | Visual China Group | Getty Images
Check out the companies making headlines before the bell.
Xpengannounced it would buy Didi’s smart electric car business in a deal worth $744 million.
3MBloomberg News reported the company tentatively agreed to resolve more than 330,000 lawsuits related to its defective earplugs. The company will pay more than $5.5 billion in the settlement, according to the report.
Akero Therapeutics initiated Akero with a buy rating and a price target that implies sharp gains ahead. UBS thinks the company’s treatment for nonalcoholic steatohepatitis could create an underappreciated market opportunity worth more than $20 billion.
Abcam — Shares of protein consumables supplier Abcam fell more than 3% after Danaher announced it would acquire the company in a deal valued at around $5.7 billion. Danaher shares gained less than 1%.
Boston Scientificannounced positive results Sunday for its treatment for patients with atrial fibrillation, or abnormal heartbeats.
— CNBC’s Jesse Pound, Sarah Min and Alexander Harring contributed reporting.